Finding new therapeutics to counter the progression of Dry AMD and prevent the geographical atrophy has never been more important. The aging population creates an ever-growing clinical need for next-generation therapeutics.

In 2020 there was an action-packed two-day agenda holds 22 Presentations from industry and academic leaders, a virtual poster session and 5+ hours of networking, you can join the only platform discussing issues present in the development of Dry AMD therapeutics.

Join this critical global forum united industry specialists from pharma, biotechs, academia and solution providers as we target the most pressing issues important to bringing the next generation of Dry AMD drugs to market